Skip to content
The Policy VaultThe Policy Vault

Mulpleta (lusutrombopag tablets) — Cigna

Thrombocytopenia in a patient with chronic liver disease who is scheduled to undergo a procedure

Initial criteria

  • Patient age ≥ 18 years
  • Patient has a current platelet count < 50 x 10^9/L (< 50,000/mcL)
  • Patient is scheduled to undergo a procedure within 8 to 14 days after starting Mulpleta therapy

Approval duration

7 days